Tweetovi
- Tweetovi, trenutna stranica.
- Tweetovi i odgovori
- Medijski sadržaj
Blokirali ste korisnika/cu @LonzaGroup
Jeste li sigurni da želite vidjeti te tweetove? Time nećete deblokirati korisnika/cu @LonzaGroup
-
How can we target tumours more precisely? By using antibody-drug conjugates. This
#cancer treatment uses#antibodies to deliver a highly potent drug into the cancer cell. http://ow.ly/Dow750yeg6r#ADCs#Lonza#WorldCancerDay
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
To acknowledge
#WorldCancerDay
, we prepared an infographic of available #CancerMedicines by type. Learn more about#cancer treatments such as#CellAndGene therapy,#Antibodies,#SmallMolecules, and more.pic.twitter.com/K1HDnsPN6l
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Lonza among top ten employers in Switzerland! One of the largest job portals in Switzerland, http://jobs.ch , recently published an annual evaluation of search queries. This year, Lonza made it into the top ten for the first timehttps://bit.ly/2RSx5A3
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
#DidYouKnow that#Lonza has two locations in Basel? Apart from the HQ in the well-known "Lonza Tower", we are also based in the Stücki Park. The building hosts several office floors and laboratories in our@LonzaDPS facility.#Basel#HappyFridaypic.twitter.com/WVZ4FPvkLJ
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
We're looking forward to working together with HES-SO Valais-Wallis to develop shared competencies in education and research!https://twitter.com/hessovalais/status/1222106491408322560 …
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Our CEO a.i. Albert M. Baehny enjoyed conversations about the recent progress of drug product manufacturing at our Lonza Stücki site in Basel.
#drugproduct#lonza#biologics@LonzaDPSpic.twitter.com/CZnMkXYMD8 – mjesto: Lonza Drug Product Services
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
"Facilitating Cell Culture Growth and Protecting Protein Integrity", interview with
#Lonza's Nicole Wellens, Global Product Manager for BioTherapeutics Media@Tech_Networkshttps://www.technologynetworks.com/biopharma/blog/facilitating-cell-culture-growth-and-protecting-protein-integrity-329667#.XigrUM3z6Ww.twitter …Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Lonza proslijedio/la je Tweet
#Lonza’s Charles Christy discusses what lies ahead for#bioprocessing in 2020, including single-use systems for mammalian manufacturing and hybrid processes for faster biologics manufacturing in@BioPharmIntl: http://bit.ly/38tAomRHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Key message from Albert Baehny, Chairman and CEO ad interim, on our
#LonzaFullYear2019 results:pic.twitter.com/FETOLpT9kL
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
The carve-out of Lonza's Specialty Ingredients segment is progressing in line with plans; completion is currently expected in mid-2020.
#LonzaFullYear2019 http://ow.ly/g6o950y0wbRHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Lonza outlook 2020: above mid-single digit sales growth, mid-term guidance 2022 confirmed, supported by solid building blocks
#LonzaFullYear2019 http://ow.ly/fQ0M50y0waxHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Specialty Ingredients (LSI) shows improved 17.8% CORE EBITDA margin, despite sales growth of -3.2%; carve-out progressing according to plan
#LonzaFullYear2019 http://ow.ly/6QNV50y0w9uHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Live from the
#LonzaFullYear2019 press conference in Zurich (CH) Read the full press release: https://www.lonza.com/about-lonza/media-center/news/Tensid/2020-01-21-06-00-English.aspx …pic.twitter.com/sWZHeSLiHm
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Pharma Biotech & Nutrition (LPBN) as driver, with 11.0% sales growth and 32.9% CORE EBITDA margin
#LonzaFullYear2019 http://ow.ly/5Xnv50y0w8LHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Lonza delivers on guidance with 6.8% sales growth, CHF 5.9bn sales, and CHF 1.6bn CORE EBITDA, resulting in a 27.4% margin
#LonzaFullYear2019 http://ow.ly/mBlo50y0w8eHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
#Lonza delivers strong full-year 2019 group results, with 11% pharma segment growth#LonzaFullYear2019 http://ow.ly/qw8q50y0w6E pic.twitter.com/wTfQNQO2We
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Lonza proslijedio/la je Tweet
#DidYouKnow There are three parameters to consider when choosing the right capsule size. Need help finding which one is best for your application? Contact us. https://lnkd.in/d3yu-2X pic.twitter.com/XRxcGt8qC0Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Lonza proslijedio/la je Tweet
For the first time,
@LonzaGroup are opening their doors for a#careers open evening! Meet the#Lonza team, take a tour of their Manchester#Finance Shared Services offices and make connections over food and drinks. Find out more & register here: http://bit.ly/38eqdlM pic.twitter.com/uFLvUSzglw
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
We’re starting 2020 on the right pedal stroke! Today,
@BikeLeague recognized Lonza with a Bronze Award for our efforts to build a bike bike-friendly workplace for our employees. Congrats to our team in Portsmouth and keep on cycling!pic.twitter.com/WxnLYwhlzi
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Lonza proslijedio/la je Tweet
Time to market for
#CellandGeneTherapy half that of other Tx (~3.5yrs) so vital to get dev right first time: Alberto Santagostino.#JPMHC20pic.twitter.com/0S5JyDGasJ
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi
Čini se da učitavanje traje već neko vrijeme.
Twitter je možda preopterećen ili ima kratkotrajnih poteškoća u radu. Pokušajte ponovno ili potražite dodatne informacije u odjeljku Status Twittera.